RxDoctor Payments Data

Robert Jensen, MD

Neuro-ophthalmology · Lexington, KYNPI 1083741961

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.6% of the total across 409 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 52 manufacturers, the largest accounting for just 7.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,901 and has fallen 97.2% since, to $81 in 2025.

$8,042in general payments, 2019–2025

Across 409 payments — averaging $19.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Biogen$617
  • EMD Serono, Inc.$541
  • Novartis$534
  • UCB, Inc.$530
  • Jazz Pharmaceuticals Inc.$448
  • Sanofi$447
  • plus $5K from 46 others

What the payments were for

  • Speaking & faculty fees$340%
  • Food & beverage$8,008100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few neuro-ophthalmology providers in Kentuckyto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$15,345
Medicare patients
79
Services billed
210

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuro-ophthalmology in Lexington

Where these figures come from

Is this you, or does something look wrong? →